US Patent 8546336 SMAC peptidometics useful as IAP inhibitors
Patent 8546336 was granted and assigned to Novartis on October, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 7, 2012
Date of Patent
October 1, 2013
Patent Application Number
13606676
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8546336 SMAC peptidometics useful as IAP inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.